ATE84065T1 - Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. - Google Patents

Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Info

Publication number
ATE84065T1
ATE84065T1 AT87114733T AT87114733T ATE84065T1 AT E84065 T1 ATE84065 T1 AT E84065T1 AT 87114733 T AT87114733 T AT 87114733T AT 87114733 T AT87114733 T AT 87114733T AT E84065 T1 ATE84065 T1 AT E84065T1
Authority
AT
Austria
Prior art keywords
expression vector
igf
growth factor
human insulin
met
Prior art date
Application number
AT87114733T
Other languages
English (en)
Inventor
Ueda Ikuo
Niwa Mineo
Saito Yoshimasa
Ishii Yoshinori
Kitaguchi Tadashi
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE84065T1 publication Critical patent/ATE84065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT87114733T 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i. ATE84065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24070286 1986-10-09
EP87114733A EP0264074B1 (de) 1986-10-09 1987-10-08 Expressionsvektor für menschlichen insulinähnlichen Wachstumsfaktor-I

Publications (1)

Publication Number Publication Date
ATE84065T1 true ATE84065T1 (de) 1993-01-15

Family

ID=17063431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87114733T ATE84065T1 (de) 1986-10-09 1987-10-08 Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.

Country Status (5)

Country Link
EP (1) EP0264074B1 (de)
AT (1) ATE84065T1 (de)
DE (1) DE3783305T2 (de)
ES (1) ES2044887T3 (de)
GR (1) GR3007491T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227993A (ja) * 1988-07-15 1990-01-30 Nippon Shinyaku Co Ltd ｈＥＧＦの製法
KR920003787B1 (ko) * 1990-03-05 1992-05-14 한국과학기술 연구원 신규 플라스미드 제조 및 그를 함유한 균주를 배양하여 아이 지 에프-1(igf-1)을 생산하는 방법
ES2178633T3 (es) * 1990-05-30 2003-01-01 Harvard College Utilizacion concomitante del factor -i de crecimiento similar a insulina (en lo sucesivo "fci-i") y el factor de crecimiento transformante beta (en la sucesivo "fct-beta") para la fabricacion de un medicamento para la regeneracion de huesos en mamiferos.
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
JPH10504971A (ja) * 1994-09-08 1998-05-19 カイロン コーポレイション インスリン様増殖因子の改善された生産方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
DK151585D0 (da) * 1985-04-03 1985-04-03 Nordisk Gentofte Dna-sekvens
DE3686365T3 (de) * 1985-06-20 2000-07-27 Fujisawa Pharmaceutical Co., Ltd. Herstellungsverfahren für humanes atriales natriuretisches Polypeptid.

Also Published As

Publication number Publication date
GR3007491T3 (de) 1993-07-30
ES2044887T3 (es) 1994-01-16
EP0264074A3 (en) 1989-10-25
DE3783305D1 (de) 1993-02-11
DE3783305T2 (de) 1993-05-19
EP0264074B1 (de) 1992-12-30
EP0264074A2 (de) 1988-04-20

Similar Documents

Publication Publication Date Title
EP0156355A3 (en) Method of improving the yield of heterologous protein produced by cultivating recombinant bacteria
EP0244234A3 (en) Transformation of trichoderma
CA2094027A1 (en) Osteogenic peptides
DE69229572D1 (de) Gliazellen-aktivierender Faktor und dessen Herstellung
ATE107958T1 (de) Herstellung eines insulinähnlichen, wachstümsfaktor bindenden proteins.
EP0228449A4 (de) Fibroblast-wachstumsfaktor.
DE3479321D1 (en) Biosynthetically produced human nerve growth factor, process for producing it, compositions containing it, dna sequence encoding it, vectors containing the sequence and host cells transformed thereby
EP0714665A3 (de) Osteogene Vorrichtungen
ATE179895T1 (de) Wundabdeckungsmaterial auf basis von kollagenfasern
DK0535060T3 (da) Antifungisk polypeptid samt fremgangsmåde til dets fremstilling
IT1223334B (it) Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
EP0404034A3 (de) DNS und ihre Verwendung
AU1582495A (en) Recombinant baculovirus and use thereof in the production of monoclonal antibodies
ZA887773B (en) Interleukin-7
AU4683489A (en) Tgf-beta 1/beta 2: a novel chimeric transforming growth factor-beta
PT90321A (pt) Processo para a preparacao de polipeptideos de veneno de vibora
DE3783305D1 (de) Expressionsvektor fuer menschlichen insulinaehnlichen wachstumsfaktor-i.
PT731811E (pt) Chaperonina 10
ATE140008T1 (de) Polypeptid
WO1991016434A3 (en) Bacillus thuringiensis cryif and cryix genes and proteins toxic to lepidopteran insects
IE801912L (en) Gaming machine
AU7151687A (en) Method of producing peptides, recombinant plasmid for use in the same and animal cells transformed with the same
NO175318C (no) Hybridgen for veksthormonfrigjörende faktor, replikerbar mikrobiell ekspresjonsvektor inneholdende et slikt gen, samt mikroorganisme transformert med en slik vektor og hybridpolypeptid som inneholder en Trp-GRF
DE3479816D1 (en) A promotor and use thereof
AU5309586A (en) Polypeptide secretion-causing vector, microorganisms transformed by said vector, and process for preparing polypeptide using said microorganisms

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee